Novartis expands Oncology pipeline with in-licensing of tislelizumab from BeiGene
Novartis has signed a strategic collaboration agreement to in-license tislelizumab from BeiGene, Ltd. in major markets outside of China, accelerating the potential for Novartis...
Brazil approves Sinovac and Astrazeneca Covid-19 vaccines for emergency use
Brazil has granted approval to AstraZeneca and Chinese firm Sinovac Biotech’c Covid-19 vaccines for emergency use, allowing the country to begin inoculation as cases...
CureVac’s COVID-19 Vaccine Candidate, CVnCoV, Demonstrated Efficient Protection of Non-Human Primates During SARS-CoV-2 Challenge Infection
CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), announced the publication of preclinical...
SII expects WHO emergency approval of Covid-19 vaccine soon
The Serum Institute of India (SII) expects to soon receive World Health Organisation (WHO) emergency use authorisation for the Oxford University/AstraZeneca Covid-19 vaccine, produced...
Thermo Fisher Scientific acquires Novasep’s Henogen for $874.5m
Thermo Fisher Scientific has acquired Novasep’s viral vector manufacturing business in Belgium, Henogen, for about €725m ($874.5m) in cash.
Founded 20 years ago, Henogen offers...
Humanigen and EVERSANA collaborate for Covid-19 drug commercialisation
Clinical-stage biopharmaceutical company Humanigen and EVERSANA have entered a partnership to make available the former’s lead drug candidate, lenzilumab, to hospitalised and hypoxic Covid-19...
Servier and X-Chem Announce Drug Discovery Collaboration in Neurological Diseases
Servier, a global pharmaceutical Group and X-Chem, Inc., a privately held drug discovery company announced a partnership to identify and develop novel small molecules...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...




























